Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2089 - 2096 of 12108 results

Mintz Lands New Chair for Sports and Entertainment Practice
November 29, 2022| News

Telephone and Texting Compliance News — November 2022
November 29, 2022| Article| Viewpoint

Telephone and Texting Compliance News: Litigation Update — Nail in the Coffin: Ninth Circuit Shuts the Door on Future ATDS Claims
November 29, 2022| Article| Viewpoint

JUST A REMINDER: Refresh Your Standard Contractual Clauses!!
November 29, 2022| Blog| Viewpoint

Mintz Hires Steven Olenick
November 29, 2022| News

Mintz Adds Ex-K&L Gates Atty As Head Of Sports Practice
November 29, 2022| News
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
